Advanced Biomed Inc Common Stock

Advanced Biomed Inc an investment holding company engages in the research and development of microfluidic biochip technologies and provides them for precision oncology detection diagnosis and treatment in Taiwan Its devices include APre a fully automated sample preparation system that enables preconcentration of diluted blood samples AC1000 a rare cell device to solve the problem of detection of hypercoagulable state samples of tumor patients ASCDrop a circulating tumor cells CTCs singlecell capture device and ACellScan an analyzer with an immunostaining chip for immunostaininganalysis of the AC1000 product The company also provides microfluidic biochips comprising APre AC1000 CTC Enrichment and ACellScan chips that are designed to provide assay products and services to cancer patients In addition its immunochromogenic kits include the ACTCE kit which is used to identify epithelial circulating tumor cells and is determined by the immunochromogenicity of EpCAM CK pan CD45 and CD14 antibodies the ACTCM kit which is used to identify mesenchymal circulating tumor cells based on the immunochromogenicity of Vimentin CD45 and CD14 antibodies the AEMT which is used to identify epithelialtomesenchymal circulating tumor cells determined by the immunochromogenicity of cellsurface Vimentin and CD45 and CD14 antibodies and the ACM which is used to identify tumorassociated macrophages based on the immunochromogenicity of PDL1 CD45 and CD14 antibodies Further the company is developing ALCGuard for early screening of lung cancer Additionally it establishes and operates medical clinics in the Peoples Republic of China The company was founded in 2014 and is headquartered in New York New York